Instrument Inactif

Autres langues Star Scientific, Inc. Nasdaq

Actions

US85517P1012

Produits pharmaceutiques

Cours en clôture Nasdaq Autres places de cotation
- ^USD	-

Autres langues

08/12/20	Rock Creek Pharmaceuticals, Inc. Went Out of Business
06/02/20	Bankruptcy Judge Changed for Rock Creek Pharmaceuticals, Inc.
21/12/18	Motion for Asset Sale Filed by Rock Creek Pharmaceuticals, Inc.
11/01/18	Motion for Asset Sale Approved for Rock Creek Pharmaceuticals, Inc.
27/09/16	Rock Creek Pharmaceuticals, Inc. Filed for Bankruptcy
29/08/16	Rock Creek Pharmaceuticals, Inc. Receives Event of Default Redemption Notice from Hudson Bay Master Fund Ltd. and from Tenor Capital Management on Behalf of Alto Opportunity Master Fund
11/08/16	Rock Creek Pharmaceuticals, Inc. Announces Earnings Results for the Second Quarter Ended June 30, 2016
08/07/16	Rock Creek Pharmaceuticals, Inc. Announces Board Changes
08/06/16	Rock Creek Pharmaceuticals, Inc. Reports Earnings results for the First Quarter Ended March 31, 2016
30/03/16	Rock Creek Pharmaceuticals, Inc. announced that it has received $0.5 million in funding.
22/03/16	Rock Creek Pharmaceuticals, Inc. Announces Earnings Results for the Year Ended December 31, 2015
22/03/16	Rock Creek Pharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt
19/11/15	Rock Creek Pharmaceuticals, Inc. Appoints Robert Scannell as Director
06/11/15	Rock Creek Pharmaceuticals, Inc.(OTCPK:RCPI) dropped from MSCI Acwi + Frontier Markets(acwi Fm) All Cap Index
06/11/15	Rock Creek Pharmaceuticals, Inc.(OTCPK:RCPI) dropped from S&P TMI Index
05/11/15	Rock Creek Pharmaceuticals, Inc.(OTCPK:RCPI) dropped from CRSP US Total Market Index
04/11/15	Rock Creek Pharmaceuticals, Inc.(NasdaqCM:RCPI) dropped from NASDAQ Composite Index
15/10/15	Rock Creek Pharmaceuticals, Inc. announced that it has received $20 million in funding from Hudson Bay Capital Management LP. and other investors.
14/10/15	Rock Creek Pharmaceuticals, Inc. announced that it expects to receive $20 million in funding from Hudson Bay Capital Management LP, and other investors.
14/09/15	Certain Common Stock of Rock Creek Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 14-SEP-2015.
20/08/15	Rock Creek Pharmaceuticals, Inc. Announces Executive Changes
10/08/15	Rock Creek Pharmaceuticals, Inc. Announces Earnings Results for the Second Quarter Ended June 30, 2015; Announces Targeting of Dermatological Disease, Updated Clinical and Regulatory Strategy
11/06/15	Rock Creek Pharmaceuticals, Inc. Announces an Update on its Clinical and Regulatory Drug Development Activities
10/06/15	Rock Creek Pharmaceuticals, Inc. Announces Executive Changes
27/05/15	Rock Creek Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2015